Clinicopathological and prognostic significance of heme oxygenase-1 expression in small intestinal adenocarcinomas

Lynch syndrome-related small intestinal adenocarcinomas

(2017) Sun-Young Jun et al.   Oncotarget

Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma

(2016) Sun-Young Jun et al.   MODERN PATHOLOGY

Pathological significance and prognostic implications of heme oxygenase 1 expression in non-muscle-invasive bladder cancer: Correlation with cell proliferation, angiogenesis, lymphangiogenesis and expression of VEGFs and COX-2

(2016) Tomohiro Matsuo et al.   Oncology Letters

Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity

(2014) Hongzhuan Yin et al.   BMC CANCER

Heme oxygenase-1 has antitumoral effects in colorectal cancer: Involvement of p53

(2014) Nancy Carolina Andrés et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAFV600Eexpression in thyroid cancer

(2014) Tao-Yeuan Wang et al.   HISTOPATHOLOGY

Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non–muscle-invasive bladder cancer

(2014) Joo Heon Kim et al.   HUMAN PATHOLOGY

Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma

(2014) Sun-Young Jun et al.   MODERN PATHOLOGY

Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients

(2013) Sang Jae Noh et al.   BMC CANCER

Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas

(2012) Norberto A. Gandini et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Expression and function of heme oxygenase-1 in human gastric cancer

(2012) Yujing Yin et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data

(2012) María S. Degese et al.   LUNG CANCER

Involvement of heme oxygenase-1 in Korean colon cancer

(2012) Kyoung Ah Kang et al.   TUMOR BIOLOGY

High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients

(2012) Jong-Rung Tsai et al.   CELLULAR ONCOLOGY

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy

(2010) Aziz Zaanan et al.   CANCER

Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder

(2010) Miyake   ONCOLOGY REPORTS

Clinical Significance of Heme Oxygenase-1 Expression in Non-Muscle-Invasive Bladder Cancer

(2010) Makito Miyake et al.   UROLOGIA INTERNATIONALIS

A Novel Experimental Heme Oxygenase-1-Targeted Therapy for Hormone-Refractory Prostate Cancer

(2009) M. A. Alaoui-Jamali et al.   CANCER RESEARCH

Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo

(2009) Philipp Nuhn et al.   Molecular Cancer

Critical Role of Endogenous Heme Oxygenase 1 as a Tuner of the Invasive Potential of Prostate Cancer Cells

(2009) G. Gueron et al.   MOLECULAR CANCER RESEARCH

Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9

(2008) C.-W. Lin et al.   MOLECULAR CANCER THERAPEUTICS